A mobile health-facilitated behavioural intervention for community health workers improves exclusive breastfeeding and early infant HIV diagnosis in India: a cluster randomized trial.
Adult
Anti-HIV Agents
/ therapeutic use
Behavior Therapy
Breast Feeding
Cluster Analysis
Community Health Workers
/ education
Counseling
Early Diagnosis
Female
HIV Infections
/ diagnosis
Humans
India
Infant
Infant, Newborn
Infectious Disease Transmission, Vertical
Nevirapine
/ therapeutic use
Pregnancy
Telemedicine
HIV
India
PMTCT uptake
behavioural intervention
mhealth
outreach workers
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
08
01
2020
revised:
19
05
2020
accepted:
28
05
2020
entrez:
4
7
2020
pubmed:
4
7
2020
medline:
13
5
2021
Statut:
ppublish
Résumé
India's national AIDS Control Organization implemented World Health Organization's option B+ HIV prevention of mother-to-child transmission (PMTCT) guidelines in 2013. However, scalable strategies to improve uptake of new PMTCT guidelines to reduce new infection rates are needed. This study assessed impact of Mobile Health-Facilitated Behavioral Intervention on the uptake of PMTCT services. A cluster-randomized trial of a mobile health (mHealth)-supported behavioural training intervention targeting outreach workers (ORWs) was conducted in four districts of Maharashtra, India. Clusters (one Integrated Counselling and Testing Center (ICTC, n = 119), all affiliated ORWs (n = 116) and their assigned HIV-positive pregnant/postpartum clients (n = 1191)) were randomized to standard-of-care (SOC) ORW training vs. the COMmunity home Based INDia (COMBIND) intervention - specialized behavioural training plus a tablet-based mHealth application to support ORW-patient communication and patient engagement in HIV care. Impact on uptake of maternal antiretroviral therapy at delivery, exclusive breastfeeding at six months, infant nevirapine prophylaxis, and early infant diagnosis at six months was assessed using multi-level random-effects logistic regression models. Of 1191 HIV-positive pregnant/postpartum women, 884 were eligible for primary outcome assessment; 487 were randomized to COMBIND. Multivariable analyses identified no statistically significant differences in any primary outcome by study arm. COMBIND was associated with higher uptake of exclusive breastfeeding at two months (adjusted Odds Ratio (aOR), 2.10; 95% CI 1.06 to 4.15) and early infant diagnosis at six weeks (aOR, 2.19; 95% CI 1.05 to 3.98) than SOC. The COMBIND intervention was easily integrated into India's existing PMTCT programme and improved early uptake of two PMTCT components that require self-motivated health-seeking behaviour, thus providing preliminary evidence to support COMBIND as a potentially scalable PMTCT strategy. Further study would identify modifications needed to optimize other PMTCT outcomes.
Identifiants
pubmed: 32618115
doi: 10.1002/jia2.25555
pmc: PMC7332965
doi:
Substances chimiques
Anti-HIV Agents
0
Nevirapine
99DK7FVK1H
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25555Subventions
Organisme : CGH CDC HHS
ID : U01 GH000731
Pays : United States
Organisme : NIH HHS
ID : D43TW009574
Pays : United States
Organisme : PEPFAR
Pays : United States
Informations de copyright
© 2020 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.
Références
J Health Commun. 2015;20 Suppl 1:67-75
pubmed: 25839204
J Int AIDS Soc. 2016 Apr 25;19(1):20679
pubmed: 27118443
Curr HIV/AIDS Rep. 2011 Dec;8(4):235-40
pubmed: 21898073
Curr HIV/AIDS Rep. 2008 Nov;5(4):193-203
pubmed: 18838059
Health Technol Assess. 2015 Apr;19(30):1-522, vii-viii
pubmed: 25897655
J Clin Epidemiol. 2014 Mar;67(3):267-77
pubmed: 24275499
AIDS. 2013 Nov 13;27(17):2809-15
pubmed: 23921609
J Virus Erad. 2018 Jan 1;4(1):51-54
pubmed: 29568555
Hum Resour Health. 2010 Mar 31;8:8
pubmed: 20356363
PLoS One. 2014 Oct 10;9(10):e108150
pubmed: 25303241
BMJ Open. 2019 Jul 29;9(7):e024907
pubmed: 31362959
AIDS. 2014 Sep 24;28(15):2307-12
pubmed: 25313586
Trop Med Int Health. 2010 Jun;15 Suppl 1:16-33
pubmed: 20586957
PLoS One. 2013 Dec 02;8(12):e81307
pubmed: 24312545
J Health Psychol. 2011 Oct;16(7):1071-81
pubmed: 21459919
Int J Epidemiol. 1999 Apr;28(2):319-26
pubmed: 10342698
AIDS Patient Care STDS. 2012 Jun;26(6):344-55
pubmed: 22612447
Lancet. 2008 Jul 26;372(9635):300-13
pubmed: 18657709
Trans R Soc Trop Med Hyg. 2009 Jun;103(6):549-58
pubmed: 18992905
J Acquir Immune Defic Syndr. 2010 Mar;53(3):405-11
pubmed: 19745753
Pediatr Infect Dis J. 2015 Mar;34(3):273-5
pubmed: 25742076
PLoS One. 2014 Nov 05;9(11):e111421
pubmed: 25372479
AIDS Care. 2011 May;23(5):593-600
pubmed: 21293983
Health Care Women Int. 2011 Apr;32(4):300-13
pubmed: 21409663
N Engl J Med. 2014 Feb 13;370(7):678
pubmed: 24521123